Viewing Study NCT05106335


Ignite Creation Date: 2025-12-24 @ 10:32 PM
Ignite Modification Date: 2025-12-25 @ 8:05 PM
Study NCT ID: NCT05106335
Status: TERMINATED
Last Update Posted: 2023-08-16
First Post: 2021-10-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate Camrelizumab Combined With Famitinib as Subsequent Therapy in Patients With Advanced NSCLC
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module